Cc1ccc(CN(C(=O)c2cc(=O)c3cc(C)cc(C)c3o2)C2CCS(=O)(=O)C2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?